New York State Common Retirement Fund’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PVLA
EA
EMFAT
CAM
LCM
New York State Common Retirement Fund's PVLA Position: Q2 2026 in Review
New York State Common Retirement Fund reduced its Palvella Therapeutics (PVLA) stake by 51% in Q2 2026, selling an estimated $1.3M and leaving 10,430 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1553.
New York State Common Retirement Fund first reported a position in PVLA in Q2 2017 and has held it in 22 quarters since. The position peaked at $2.64M in Q1 2026. 63 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.
- New York State Common Retirement Fund held 10,430 shares of Palvella Therapeutics worth $1.59M as of Q2 2026.
- New York State Common Retirement Fund sold 10,712 Palvella Therapeutics shares in Q2 2026, an estimated $1.3M.
- Palvella Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1553 holding.
- New York State Common Retirement Fund first reported a position in Palvella Therapeutics in Q2 2017 and has held it in 22 quarters since.
- New York State Common Retirement Fund's Palvella Therapeutics position peaked at $2.64M in Q1 2026.
- 63 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.